NEW PERSPECTIVES IN PEDIATRIC NEUROMUSCULAR DISORDERS Hotel Intercontinental Sydney,Sydney,Australia,August 28,1998

Dubowitz V. : 22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14-16 May, 1993. Neuromuscul Disord 1994;4:75-81.

Dubowitz V. , Fardeau M. : Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy, The Netherlands, 22-24 April, 1994. Neuromuscul Disord 1995;5:253-258.

Dubowitz V. : 41st ENMC international workshop on congenital muscular dystrophy, Naarden, The Netherlands, 8-10 March, 1996. Neuromuscul Disord 1996;6:295-306.

Dubowitz V. : 50th ENMC international workshop: Congenital muscular dystrophy, Naarden, The Netherlands, 28 February-2 March, 1997. Neuromuscul Disord 1997;7:539-547.

Echenne B. : Congenital muscular dystrophy, in Lane RJM (ed): Handbook of Muscle Disease. New York, Marcel Dekker, 1996, pp 139-150.

Fardeau M. , Tome Fms , Helbling-Leclerc A. , et al: Congenital muscular dystrophy, in Cornelio F , et al (eds): Neuromuscular Diseases During Development . London, John Libbey, 1997, pp 23-30.

Fukuyama Y. : Congenital muscular dystrophy: An overview, in Arzimanoglou A , Goutieres F (eds): Trends in Child Neurology. Paris, John Libbey, 1996, pp 107-135.

Fukuyama Y , Osawa M , Saito K (eds): Congenital Muscular Dystrophies . Amsterdam, Elsevier, 1997.

Kobayashi K. , Toda T. : An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998;394: 388-392.

Tome Fms , Guicheney P. , Fardeau M. : Congenital muscular dystrophies, in Emery AEH (ed): Neuromuscular Disorders: Clinical and Molecular Genetics. Chichester, John Wiley , 1998, pp 21-57.

Voit T. : Congenital muscular dystrophies: 1997 update. Brain Dev 1998;20:65-74.

Emery Aeh : Diagnostic Criteria of Neuromuscular Disorders, 2nd ed. London, Royal Society of Medicine Press, 1997.

Goebel HH : Congenital myopathies. Semin Pediatr Neurol 1996;3: 152-161.

Goebel HH , Fidzianska A. : Classification of congenital myopathies, in RJM Lane (ed): Handbook of Muscle Disease. New York, Marcel Dekker, 1996.

North KN , Laing G. , Wallgren-Pettersson C. : Nemaline myopathy: Current concepts. J Med Genet 1997;34:705-713.

Wallgren-Pettersson C. , Laing NG : Workshop report: 40th ENMC international workshop: Nemaline myopathy. 2-4 February, 1996, Naarden, The Netherlands . Neuromuscul Disord 1996;6:389-391.

Wallgren-Pettersson C. , Beggs AH , Laing NG : 51st ENMC international workshop: Nemaline myopathy. 3-15 June, 1997, Naarden, The Netherlands . Neuromuscul Disord 1998;8: in press.

Goebel HH , Warlo I. : Nemaline myopathy with intranuclear rods— intranuclear rod myopathy . Neuromuscul Disord 1997;7:13-19.

Laporte J. , et al: Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. Hum Mol Genet 1997;6:1505-1511.

Wallgren-Pettersson C. , Thomas Nst : Report on the 20th ENMC sponsored international workshop: Myotubular/centronuclear myopathy. Neuromuscul Disord 1994;4:71-74.

Thomas N. , Wallgren-Pettersson C. : Report of the 33rd ENMC sponsored international workshop: X-linked myotubular myopathy. Neuromuscul Disord 1996 ;6:129-132.

Wallgren-Pettersson C. , Thomas N. : 45th ENMC international workshop: Myotubular myopathy. 13-15th September, 1996, Naarden, The Netherlands . Neuromuscul Disord 1997;7:268-271.

Goebel HH : Congenital myopathies with inclusion bodies: A brief review. Neuromuscul Disord 1998;8: in press.

Anderson J. , Goebel HH : Structural congenital myopathies—56th ENMC sponsored international workshop. Neuromuscul Disord 1998;8: in press.

Goebel HH , Fardeau M. : Desmin in myology—Report on the 24th ENMC sponsored international workshop . Neuromuscul Disord 1995;5:161-166.

Goebel HH , Fardeau M. : Familial desmin-related myopathies and cardiomyopathies—36th ENMC sponsored international workshop. Neuromuscul Disord 1996;6:383-388.

Goebel HH , Anderson JR , Hübner C. , et al: Congenital myopathy with excess of thin myofilaments. Neuromuscul Disord 1997;7:160-168.

Bushby KM , Beckmann JS : The limb girdle muscular dystrophies— proposal for a new nomenclature . Neuromuscul Disord 1995;4:337-343.

Weiler T. , Greenberg CR , Nylen E. , et al: Limb girdle muscular dystrophy in Manitoba Hutterites does not map to any of the known LGMD loci. Am JMed Genet 1997;72:363-368.

Moreira ES , Vainzof M. , Marie SK , et al: The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet 1997;61:151-159.

van der Kooi AJ , Ginjaar HB , Busch Hfm , et al: Limb girdle muscular dystrophy: A pathological and clinical reevaluation. Muscle Nerve 1997;21:584-590.

Passos-Bueno MR , Moreira ES , Marie SK , et al: Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families. J Med Genet 1996;33:97-102.

Dincer P. , Leturcq F. , Richard I. , et al: A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 1997;42:222-229.

Vainzof M. , Passos-Bueno MR , Moreira ES , et al: The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996;5:1963-1969.

Eymard B. , Romero NB , Leturcq F. , et al: Primary adhalinopathy (alphasarcoglycanopathy): Clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy . Neurology 1997;48:1227-1234.

Carrie A. , Piccolo F. , Leturcq F. , et al: Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet 1997;34:470-475.

Bönnemann CG , Passos-Bueno R. , McNally EM , et al: Genomic screening for β-sarcoglycan mutations: Missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet 1996;5:1953-1961.

McNally EM , Duggan DJ , Gorospe JR , et al: Mutations in the carboxyl-terminus of γ-sarcoglycan cause muscular dystrophy. Hum Mol Genet 1996;5:1841-1847.

McNally EM , Passos-Bueno R. , Bönnemann CG , et al: Mild and severe muscular dystrophy caused by a single γ-sarcoglycan mutation. Am J Hum Genet 1996;59:1040-1047.

Fardeau M. , Hillaire D. , Mignard C. , et al: Juvenile limb-girdle muscular dystrophy: Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996;119:295-308.

Richard I. , Brenguier L. , Dincer P. , et al: Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet 1997;60:1128-1138.

Mahjneh I. , Passos-Bueno MR , Zatz M. , et al: The phenotype of chromosome 2p-linked limb girdle muscular dystrophy . Neuromuscul Disord 1996;6:491-492.

Speer MC , Gilchrist JM , Stajich JM , et al: Evidence for anticipation in autosomal dominant limb-girdle muscular dystrophy. J Med Genet 1998;35:305-308.

Minetti C. , Sotgia F. , Bruno C. , et al: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998;18:365-368.

Song KS , Scherer PE , Tang Z. , et al: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996;271:15160-15165.

Dubowitz V. : Report on the 41st EMNC sponsored international workshop on congenital muscular dystrophy. Neurmuscul Disord 1996;6:295-306.

Li M. , Dickson DW , Spiro AJ : Abnormal expression of laminin β1 chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy. Arch Neurol 1997;54:1457-1461.

Bonilla E. , Fischbeck K. , Schotland DL : Freeze-fracture studies of muscle caveolae in human muscular dystrophy . Am J Pathol 1981;104: 167-173.

Song KS , Scherer PE , Tang ZL , et al: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J Biol Chem 1996;271: 15161-15165.

Minetti C. , Sotgia F. , Bruno C. , et al: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genet 1998;18:365-368.

McNally EM , de Sa Moreira E. , Duggan DJ , et al: Caveolin-3 in muscular dystrophy. Hum Mol Genet 7:871-877.

Drachman DA , Wetzel N. , Wasserman M. , Naito H. : Experimental denervation of ocular muscles. A critique of the concept of "ocular myopathy." Arch Neurol 1969;21:170-183.

Porter J. , Baker R. : Muscles of a different "color": The unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease . Neurology 1996;46:30-37.

Porter J. , Karathanasis P. , Bonner P. , Brueckner J. : The oculomotor periphery: The clinician's focus is no longer a basic science stepchild. Curr Opin Neurobiol 1997 ;7:880-887.

Leigh R. , Zee D. : The neurology of eye movements, in Plum F (ed): Contemporary Neurology Series, vol 1. Philadelphia, FA Davis 1991, pp 293—377.

Brown HW : Congenital structural muscle anomalies, in Allen JH (ed): Strabismus Ophthalmic Symposium. St Louis, CV Mosby, 1950, pp 205-236.

Crawford JS : Congenital fibrosis syndrome. Can J Ophthalmol 1970;5:331-336.

Apt L. , Axelrod RN : Generalized fibrosis of the extraocular muscles. Am J Ophthalmol 1978;85:822-829.

Engle EC , Goumernov B. , McKeown CA , et al: Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann Neurol 1997 ;41:314-325.

Hotchkiss MG , Miller NR , Clark AW , Green WG : Bilateral Duane's retraction syndrome: A clinical-pathological case report. Arch Ophthalmol 1980;98:870-874.

Miller NR , Kiel SM , Green WR , Clark AW : Unilateral Duane's retraction syndrome (type 1). Arch Ophthalmol 1982;100: 1468-1472.

Engle EC : The genetics of strabismus: Duane, Moebius, and Fibrosis syndromes , in E T (ed): Genetic Diseases of the Eye: A Textbook and Atlas. New York, Oxford University Press, in press.

Laughlin RC : Congenital fibrosis of the extraocular muscles; a report of six cases. Am J Ophihalmol 1956 ;41:432-438.

Engle EC , Kunkel LM , Specht LA , Beggs AH : Mapping a gene for congenital fibrosis of the extraocular muscles to the centromeric region of chromosome 12. Nat Genet 1994;7:69-73.

Engle EC , Marondel I. , Houtman WA , et al: Congenital fibrosis of the extraocular muscles (autosomal dominant congenital external ophthalmoplegia): Genetic homogeneity, linkage refinement, and physical mapping on chromosome 12. Am J Hum Genet 1995;57:1086-1094.

Houtman WA , van Weerden TW , Robinson PH , et al: Hereditary congenital external ophthalmoplegia. Ophthalmologica 1986;193:207-218.

Cibis GW : Congenital familial external ophthalmoplegia with co-contraction. Ophthal Paediatr Genet 1984;4:163-168.

Wang S. , Zwaan J. , Mullaney P. , et al: Congenital fibrosis of the extraocular muscles type 2 (CFEOM2), an inherited exotropic strabismus fixus, maps to distal 11q13. Am J Hum Genet 1998; in press.

Engle EC , Castro AE , Macy ME , et al: A gene for isolated congenital ptosis maps to a 3-cM region within 1p32-p34.1. Am J Hum Genet 1997;60:1150-1157.

Engel AG : Myasthenic syndromes, in Engel AG , Franzini-Armstrong C (eds): Myology: Basic and Clinical, 2nd ed. New York , McGraw-Hill, 1994, pp 1798-1835.

Ohno K. , Hutchinson DO , Milone M. , et al: Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit. Proc Natl Acad Sci USA 1995;92:758-762.

Sine SM , Ohno K. , Bouzat C. , et al: Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 1995;15:229-239.

Engel AG , Ohno K. , Milone M. , et al: New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996;5:1217-1227.

Milone M. , Wang H-L. , Ohno K. , et al: Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 1997;17:5651-5665.

Ohno K. , Quiram P. , Milone M. , et al: Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ε subunit gene: Identification and functional characterization of six new mutations. Hum Mol Genet 1997;6:753-766.

Ohno K. , Wang H-L. , Milone M. , et al: Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron 1996;17:157-170.

Ohno K. , Engel AG , Milone M. , et al: A congenital myasthenic syndrome with severe acetylcholine receptor deficiency caused by heteroallelic frameshifting mutations in the epsilon subunit, abstract. Neurology 1995;45(Suppl 4):A283.

Milone M. , Ohno K. , Pruitt JN , et al: Congenital myasthenic syndrome due to a frameshifting acetylcholine receptor epsilon subunit mutation. Soc Neurosci Abstr 1996;22:1942.

Ohno K. , Fukudome T. , Nakano S. , et al: Mutational analysis in a congenital myasthenic syndrome reveals a novel acetylcholine receptor epsilon subunit mutation. Soc Neurosci Abstr 1996;22:234.

Engel AG , Ohno K. , Bouzat C. , et al: End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit. Ann Neurol 1996;40:810-817.

Milone M. , Wang H-L. , Ohno K. et al: Mode-switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor ε subunit . Neuron 1998;20:575-588.

Ohno K. , Anlar B. , Özdemir C. , et al: Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor. Ann Neurol 1998 ; in press.

Ohno K. , Hutchinson DO , Milone M. , et al: Molecular genetic basis of a slow channel syndrome, abstract . Muscle Nerve 1995;18:463.

Wang H-L. , Auerbach A. , Bren N. , et al: Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol 1997;109:757-766.

Gomez CM , Maselli R. , Gammack J. , et al: A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Ann Neuro L 1996;39:712-723.

Croxen R. , Newland C. , Beeson D. , et al: Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1997;6:767-773.

Gomez CM , Gammack JT : A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 1995;45:982-985.

Sieb JP , Milone M. , Engel AG : Effects of the quinoline derivatives quinine, guinidine, and chloroquine on neuromuscular transmission. Brain Res 1996 ;712:179-189.

Fukudome T. , Ohno K. , Brengman JM , Engel AG : Quinidine sulfate normalizes the open duration of slow channel congenital myasthenic syndrome acetylcholine receptor channels expressed in human embryonic kidney cells, abstract. Neurology 1997;48:A72. Neuroreport, June 1, 1998.

Harper CM , Engel AG : Quinidine sulfate in the treatment of the slow channel congenital myasthenic syndrome, abstract. Neurology 1997 ;48:A72. Ann Neurol 1998; in press.

Uchitel O. , Engel AG , Walls TJ , et al: Congenital myasthenic syndromes. II. A syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle Nerve 1993;16:1293-1301.

Hesselmans Lfgm , Jennekens Fgi , Vand Den Oord Cjm , et al: Development of innervation of skeletal muscle fibers in man: Relation to acetylcholine receptors. Anat Rec 1993;236:553-562.

Witzemann V. , Schwartz H. , Koenen M. , et al: Acetylcholine receptor epsilon subunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proc Natl Acad Sci USA 1996 ;93:13286-13291.

Villarroel A. , Sakmann B. : Calcium permeability increase of endplate channels in rat muscle during postnatal development. J Physiol (Lond) 1996;496:331-338.

Croxen R. , Beeson D. , Vincent A. , Newsom-Davis J. : Congenital myasthenic syndrome with a single nucleotide deletion at the intron/exon boundary in exon 12 of the gene encoding the acetylcholine receptor ε subunit, abstract. Ann Neurol 1996;40:513.

Newsom-Davis J. : Autoimmune and genetic disorders at the neuromuscular junction. Dev Med Child Neurol 1998;40:199-206.

Newsom-Davis J. : Autoimmune neuromyotonia (Isaacs' syndrome): An antibody-mediated potassium channelopathy. Ann N Y Acad Sci 1997; 835:111-119.

Newsom-Davis J. : Autoantibody-mediated channelopathies at the neuromuscular junction. Neuroscientist 1997;3:337-346.

Waterman SA , Lang B. , Newsom-Davis J. : Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 1997;42:147-156.

Hart IK , Waters C. , Vincent A. , et al: Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-246.

Riemersma S. , Vincent A. , Beeson D. , et al: Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest 1996;98:2358-2363.

Vincent A. , Newland C. , Brueton L. , et al: Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 1995;346:24-25.

Rodriguez M. , Gomez MR , Howard FM , Taylor WF : Myasthenia gravis in children: Long term follow-up. Ann Neurol 1983;13:504-510.

Chelmicka-Schorr E. , Bernstein LP , Zurbrugg EB , Huttenlocher PR : Eaton-Lambert syndrome in a 9-year-old girl . Arch Neurol 1979;36: 572-574.

Isaacs H. : A syndrome of continuous muscle-fiber activity. J Neurol Neurosurg Psychiatry 1961;24:319-325.

Munsat TL : Workshop report: International SMA collaboration. Neuromuscul Disord 1991;1:81.

Melki J. , Lefebvre S. , Burglen L. , et al: De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 1994;264: 1474-1477.

Lefebvre S. , Burglen L. , Reboullet S. , et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80:155-165.

Bussaglia E. , Clermont O. , Tizzano E. , et al: A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 1995;11:335-337.

Rodrigues NR , Owen N. , Talbot K. , et al: Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet 1995;4:631-634.

van der Steege G. , Grootscholten PM , van der Vlies P. , et al: PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995;345:985-986.

Parsons DW , McAndrew PE , Monani UR , et al: An 11 base pair duplication in exon 6 of the SMN gene produces a type spinal muscular atrophy (SMA) phenotype: Further evidence of SMN as the primary SMA-determining gene. Hum Mol Genet 1996;5:1727-1732.

Brahe C. , Clermont O. , Zappata S. , et al: Frameshift mutation in the survival motor neuron gene in a severe case of SMA type 1. Hum Mol Genet 1996;5:1971-1976.

Liu Q. , Dreyfuss G. : A novel nuclear structure containing the survival of motor neuron protein . EMBO J 1996; 15:3555-3565.

Liu Q. , Fischer U. , Wang F. , Dreyfuss G. : The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 1997;90:1013-1021.

Fischer U. , Liu Q. , Dreyfuss G. : The SMN-SIP1 complex has an essential role in the spliceosomal snRNP biogenesis . Cell 1997;90:1023-1029.

Lefebvre S. , Burlet P. , Liu Q. , et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997;16:265-269.

Coovert DD , Le TT , McAndrew PE , et al: The survival motor neuron protein in spinal muscular atrophy . Hum Mol Genet 1997;6:1205-1214.

Lupski JR , Garcia CA , Parry GJ , Patel PI : Charcot-Marie-Tooth polyneuropathy syndrome: Clinical, electrophysiological and genetics aspects, in Appel S (ed): Current Neurology. Chicago, Mosby-Yearbook, 1991, pp 1-25.

Dyck PJ , Chance PF , Lebo RV , Carney JA : Hereditary motor and sensory neuropathies, in Dyck PJ , Thomas PJ , Griffin JW , et al (eds): Peripheral Neuropathy , 3rd ed. Philadelphia, WB Saunders, 1993, pp 1094-1136.

Bird TD , Kraft GK : Charcot-Marie-Tooth disease: Data for genetic counselling. Clin Genet 1978;14:43-49.

Bird TD , Ott J. , Giblett ER : Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet 1982 ;34:388-394.

Stebbins NB , Conneally PM : Linkage of dominantly inherited Charcot-Marie-Tooth neuropathy to the Duffy locus in an Indiana family. Am J Hum Genet 1982;34:195A.

Bird TD , Ott J. , Giblett ER , et al: Genetic linkage evidence for heterogeneity in Charcot-Marie-Tooth neuropathy (HMSN type I). Ann Neurol 1983;14:679-684.

Dyck PJ , Ott J. , Breanndan MS , et al: Linkage evidence for genetic heterogeneity among kinships with hereditary motor and sensory neuropathy, type I. Mayo Clin Proc 1983;58:430-435.

Vance JM , Nicholson GA , Yamaoka LH , et al: Linkage of Charcot-Marie-Tooth neuropathy type IA to chromosome 17. Exp Neurol 1989; 104:186-189.

Raeymaekers P. , Timmerman V. , De Jonghe P , et al: Localization of the mutation in an extended family with Charcot-Marie-Tooth neuropathy (HMSN I). Am J Hum Genet 1989;45:953-958.

Chance PF , Bird TD, O'Connell , et al: Linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy I). Am J Hum Genet 1990;47:915-925.

McAlpine PJ , Feasby TE , Hahn AF , et al: Charcot-Marie-Tooth neuropathy type IA (CMT1A) maps to chromosome 17. Genomics 1990;7:408-415.

Middleton-Price HR , Harding AE , Monteiro C. , et al: Linkage of hereditary motor and sensory neuropathy type I to the pericentromeric region of chromosome 17. Am J Hum Genet 1990;46:92-94.

Patel PI , Franco B. , Garcia C. , et al: Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: Identification of new linked markers on chromosome 17. Am J Hum Genet 1990;46:801-809.

Vance JM , Barker D. , Yamaoka LH , et al: Localization of Charcot-Marie-Tooth disease type 1A (CMT1A) to chromosome 17p11.2. Genomics 1991;9:623-628.

Lupski JR , de Oca-Luna RM , Slaugenhaupt S. , et al: DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66: 219-232.

Raeymaekers P. , Timmerman V. , Nelis E. , et al: Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1A. Neuromuscul Disord 1991;1:93-97.

Raeymaekers P. , Timmerman V. , Nelis E. , et al: Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1A (CMT1A). J Med Genet 1992;29:5-11.

Wright EC , Goldgar DE , Fain PR , et al: A genetic map of human chromosome 17p. Genomics 1990;7:103-109.

Hoogendijk JE , Hensels GW , Gabreëls-Festen AA , et al: De-novo mutation in hereditary motor and sensory neuropathy type 1. Lancet 1992; 339:1081-1082.

Blair IP , Nash J. , Gordon MJ , Nicholson GA : Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin . Am J Hum Genet 1996;58:472-476.

Ionasescu W. , Ionasescu R. , Searby C. , et al: Charcot-Marie-Tooth neuropathy type 1A with both duplication and non-duplication. Hum Mol Genet 1993;2:405-410.

Valentijn LJ , Baas F. , Zorn I. , et al: Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 1993;2:2143-2146.

Feldman GM , Baumer JG , Sparkes RS : Brief clinical report: The dup(17p) syndrome. Am J Med Genet 1982;11:299-304.

Magenis RE , Brown MG , Allen L. , et al: De novo partial duplication of 17p (dup(17)(p12-p11.2)): Clinical report. Am J Med Genet 1986;24: 415-420.

Chance PF , Bird TD , Matsunami N. , et al: Trisomy 17p associated with Charcot-Marie-Tooth neuropathy I phenotype: Evidence for gene dosage as a mechanism in CMT1A. Neurology 1992;42:2295-2299.

Lupski JR , Wise CA , Kuwano A. , et al: Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:29-33.

Falconer DS : Two new mutants, "Trembler" and "Reeler" with neurological actions in the mouse (Mus musculus L.). J Genet 1951;50:192-201.

Aguayo JA , Attiwell M. , Trecarten J. , et al: Abnormal myelination in transplanted trembler mouse Schwann cells. Nature 1977;265:73-75.

Davisson MT , Roderick TH : Status of the linkage map of the mouse. Cytogenet Cell Genet 1978;22:552-557.

Buchberg AM , Brownell E. , Nagata S. , et al: A comprehensive genetic map of murine chromosome 11 reveals extensive linkage conservation between mouse and human . Genetics 1988;122:153-161.

Suter U. , Welcher AA , Ozcelik T. , et al: Trembler mouse carries a point mutation in a myelin gene. Nature 1992;356:241-244.

Manfioletti G. , Ruaro ME , Del Sal G. , et al: A growth arrest-specific (gas) gene codes for a membrane protein. Mol CeU Biol 1990;10:2924-2930.

Spreyer P. , Kuhn G. , Hanemann C. , et al: Axon-regulated expression of a Schwann cell transcript that is homologous to a growth arrest-specific gene. EMBO J 1991;10:3661-3668.

Welcher AA , Suter U. , De Leon M. , et al: A myelin protein is encoded by the homolog of a growth arrest-specific gene. Proc Natl Acad Sci USA 1991;88:7195-7199.

Matsunami N. , Smith B. , Ballard L. , et al: Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992;1:176-179.

Patel PI , Roa BB , Welcher AA , et al: The gene for the peripheral myelin protein PMP22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:157-165.

Timmerman V. , Nelis E. , Van Hul W. , et al: The peripheral myelin protein gene PMP22 is contained within the Charcot-Marie-Tooth disease type 1A duplication . Nat Genet 1992;1:171-175.

Valentijn LJ , Bolhuis PA , Zorn I. , et al: The peripheral myelin gene PMP22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:166-170.

Snipes GJ , Suter U. , Welcher AA , et al: Characterization of a novel peripheral nervous system myelin protein (PMP22/SR13). J Cell Biol 1992;117:225-238.

Suter U. , Snipes GJ , Schoener-Scott R. , et al: Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 1994;26:25795-25808.

Yoshikawa H. , Nishimura T. , Fujimura H. , et al: Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerve of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;35:445-450.

Valentijn LJ , Baas F. , Wolterman RA , et al: Identical point mutations of the peripheral myelin protein-22 in trembler-J mouse and a family with Charcot-Marie-Tooth disease. Nat Genet 1992 ;2:288-291.

Roa BB , Garcia CA , Suter U. , et al: Charcot-Marie-Tooth diseases type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101.

Gabreëls-Festen AA , Bolhuis PA , Hoogendijk JE , et al: Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations . Acta Neuropathol (Berl) 1995;90: 645-649.

Wise CA , Garcia CA , Davis SN , et al: Molecular analysis of unrelated Charcot-Marie-Tooth disease patients suggests a high frequency of the CMT1A duplication. Am J Hum Genet 1993;53:853-863.

Hayasaka K. , Nanao K. , Tahara M. , et al: Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin. Biochem Biophys Res Commun 1991;180:515-518.

Lemke G. : The molecular genetics of myelination: An update. Glia 1993; 7:263-271.

Hayasaka K. , Himoro M. , Sato W. , et al: Charcot-Marie-Tooth neuropathy type 1b associated with mutations in the myelin protein zero gene . Nat Genet 1993;5:31-34.

Kulkens T. , Bolhuis PA , Wolterman RA , et al: Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B. Nat Genet 1993;5:35-39.

Hayasaka K. , Takada G. , Ionasescu VV : Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B. Hum Mol Genet 1993;2: 1369-1372.

Warner LE , Hilz MJ , Appel SH , et al: Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination . Neuron 1996;17:451-460.

Roa BB , Warner LE , Garcia CA , et al: Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease. Hum Mutat 1996 ;7:36-45.

Gabreëls-Festen AA , Hoogendijk JE , Meijerink PH , et al: Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 1996;47:761-765.

Nelis E. , Timmerman V. , De Jonghe P , et al: Rapid screening of myelin genes in CMT1 patients by SSCP analysis: Identification of new mutations and polymorphisms in the Po gene. Hum Genet 1995.

Roa BB , Dyck PJ , Marks HG , et al: Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993;5:269-273.

Hayasaka K. , Himoro M. , Sawaishi Y. , et al: De novo mutation of the myelin P0 gene in Dejerine-Sottas disease. Nat Genet 1993;5:66-268.

Rautenstrauss B. , Nelis E. , Grehl H. , et al: Identification of a de novo insertional mutation in Po in a patient with a Dejerine-Sottas phenotype. Hum Mol Genet 1994;3:1701-1702.

Windebank AJ : Inherited recurrent focal neuropathies, in Dyck PJ , Thomas PJ , Griffin JW , et al (eds): Peripheral Neuropathy , 3rd ed. Philadelphia, WB Saunders, 1993 , pp 1137-1148.

Dyck PJ , Oviatt KF , Lambert EH : Intensive evaluation of unclassified neuropathies yields improved diagnosis . Ann Neurol 1981;10:222-226.

Madrid R. , Bradley WG : The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy): Studies on the formation of the abnormal myelin sheath. J Neurol Sci 1975;25: 415-418.

Chance PF , Alderson MK , Leppig KA , et al: DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-151.

Marimann Ecm , Gabreëls-Festen Aavm , van Beersum Sec , et al: The gene for hereditary neuropathy with liability to pressure palsies (HNPP) maps to chromosome 17 at or close to the locus for HMSN type I. Hum Genet 1993 ;93:87-90.

Le Guem E. , Sturtz F. , Gugenheim M. , et al: Detection of deletion within 17p11.2 in 7 French families with hereditary neuropathy with liability to pressure palsies (HNPP). Cytogenet Cell Genet 1994;65:261.

Nicholson GA , Valentijn LJ , Cherryson AK , et al: A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 1994;6:263-266.

Marimann Ecm , Gabreëls-Festen Aavm , van Beersum Sec , et al: Evidence for genetic heterogeneity underlying hereditary neuropathy with liability to pressure palsies. Hum Genet 1994;93:151-156.

Pentao L. , Wise CA , Chinault AC , et al: Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet 1992;2:292-300.

Chance PF , Abbas N. , Lensch MW , et al: Two autosomal dominant neuropathies result from reciprocal duplication/deletion of a region of chromosome 17. Hum Mol Genet 1994;3:223-228.

Kiyosawa H. , Lensch MW , Chance PF : Analysis of the CMT1A-REP repeat: Mapping crossover breakpoints in CMT1A and HNPP. Hum Mol Genet 1995;2327-2334.

Reiter LT , Murakami T. , Koeuth T. , et al: A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 1996;12:288-297.

Kiyosawa H. , Chance PF : Primate origin of the CMT1A-REP repeat and an analysis of a putative transposon-associated recombinational hotspot. Hum Mol Genet 1996;5:745-754.

Lopes J. , LeGuern E. , Gouider R. , et al: Recombination hot spot in a 3.2 kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to presssure palsies and of Charcot-Marie-Tooth type 1A. Am J Hum Genet 1996;58:1223-1230.

Martini R. , Zielasek J. , Toyka KV , et al: P0-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 1995;11:281-286.

Adlkofer K. , Martini R. , Aguzzi A. , et al: Hypermyelination and demyelinating peripheral neuropathy in pmp22 deficient mice. Nat Genet 1995;11:274-280.

Scherer SS , Chance PF : Myelin genes: Getting the dosage right. Nat Genet 1995;11:226-228.

Tsairis P. , Dyck PJ , Mulder DW : Natural history of brachial plexus neuropathy. Arch Neurol 1972;27:109-117.

Jacob JC , Andermann F. , Robb JP : Heredofamilial neuritis with brachial predilection. Neurology 1961;11:1025-1033.

McKusick VA : Mendelian Inheritance in Man, 10th ed. Baltimore, Johns Hopkins University Press, 1992.

Bradley WG , Madrid R. , Thrush DC , Campbell MJ : Recurrent brachial plexus neuropathy. Brain 1975;98:381-398.

Martinelli P. , Fabbri R. , Moretto G. , et al: Recurrent familial brachial plexus palsies as the only clinical expression of tomaculous neuropathy . Eur Neurol 1989;29:61-66.

Gouider R. , Le Guern E , Emile P. , et al: Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: Two distinct clinical, electrophysiological and genetic entities. Neurology 1994;44:2250-2252.

Chance PF , Lensch MW , Lipe H. , et al: Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: Two distinct genetic disorders. Neurology 1994;44:2253-2257.

Windebank AJ , Schenone A. , Dewald G. : Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy: Two genetically distinct disorders. Mayo Clin Proc 1995;70:743-746.

Pellegrino JE , Rebbeck TR , Brown MJ , et al: Mapping of hereditary neuralgic amyotrophy (familial brachial plexus neuropathy) to distal chromosome 17q. Neurology 1996;46:1128-1132.

Loprest LJ , Pericak-Vance MA , Stajich J. , et al: Linkage studies in Charcot-Marie-Tooth disease type 2: Evidence that CMT1 and CMT2 are distinct genetic entities. Neurology 1992;42:597-601.

Ben Othmane K , Middleton LT , Loprest LJ , et al: Localization of a gene for autosomal dominant Charcot-Marie-Tooth type to chromosome 1p and evidence for genetic heterogeneity. Genomics 1993;17:370-375.

Kwon JM , Elliot JL , Yee W. , et al: Assignment of a second locus for Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995;57:853-858.

Dyck PJ , Litchy WJ , Minnerath S. , et al: Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994; 35:608-615.

Yoshioka R. , Dyck PJ , Chance PF : Genetic heterogeneity in Charcot-Marie-Tooth neuropathy type 2. Neurology 1996;46:569-571.

Allan W. : Relation of hereditary pattern to clinical severity as illustrated by peroneal atrophy. Arch Intern Med 1939;63:1123-1131.

Fryns JP , Van den Berghe H. : Sex-linked recessive inheritance in Charcot-Marie-Tooth disease with partial manifestations in female carri- E ers. Hum Genet 1980;55:413-415.

Gal A. , Mucke J. , Theile H. , et al: X-linked dominant Charcot-Marie-Tooth disease: Suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum Genet 1985;70:38-42.

Fischbeck KH , ar Rushdi N. , Pericak-Vance M. , et al: X-linked neuropathy: Gene localization with DNA probes. Ann Neurol 1986;20: 527-532.

Ionasescu VV , Trofatter JL , Haines JL , et al: Mapping of the gene for X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 1992; 42:903-908.

Mostacciuolo ML , Muller E. , Fardin P. , et al: X-linked Charcot-Marie-Tooth disease: A linkage study in a large family using 12 probes of the pericentric region . Hum Genet 1991;87:23-27.

Ionasescu VV , Trofatter J. , Haines JL , et al: Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy. Am J Hum Genet 1991;8: 1075-1083.

Bergoffen J. , Trofatter J. , Pericak-Vance MA , et al: Linkage localization of X-linked Charcot-Marie-Tooth disease. Am J Hum Genet 1993;52: 312-318.

Fain PR , Barker DF , Chance PF : Refmed genetic mapping of the X-linked Charcot-Marie-Tooth neuropathy locus . Am J Hum Genet 1994; 1 54:229-235.

Bergoffen J. , Scherer SS , Wang S. , et al: Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262:2039-2042.

Fairweather N. , Bell C. , Cochrane S. , et al: Mutations in the connexin32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX) . Hum Mol Genet 1994;3:29-34.

Ionasescu V. , Searby C. , Ionasescu R. : Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy . Hum Mol Genet 1994;3:355-358.

Ionasescu VV , Searby C. , Ionasescu R. , et al: Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy . Neurology 1996;47:541-544.

Bone LJ , Dahl N. , Lensch MW , et al: New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology 1995;45: 1863-1866.

Ben Othmane K , Hentati F. , Lennon F. , et al: Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum Mol Genet 1993;2:1625-1628.

Igarashi M. , Thompson E. , Rivera GK : Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy). Med Pediatr Oncol 1995;25:113-116.

Graf WD , Chance PF , Lensch MW , et al: Charcot-Marie-Tooth disease type 1A with the 17p11.2-12 duplication predisposes to severe vincristine neuropathy. Cancer 1996;77:1356-1362.

Neumann Y. , Toren A. , Rechavi G. , et al: Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease . Med Pediatr Oncol 1996;26:280-283.

Nicholson GA : Penetrance of the hereditary motor and sensory neuropathy type 1A mutation: Assessment by nerve conduction studies. Neurology 1991;41:547-552.

Ionasescu VV : Charcot-Marie-Tooth neuropathies: From clinical description to molecular genetics. Muscle Nerve 1995;18:267-275.

Gabreëls-Festen Aawm , et al: Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci 1992; 107:145-154.

Hahn A. , et al: X-linked dominant Charcot-Marie-Tooth disease: Connexin32 mutations and their relationship to clinical and pathological disease. PNS meeting, Cambridge, July 9-12, 1997.

Sander S. , et al: Charcot-Marie-Tooth disease: Histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1). Muscle Nerve 1998; in press.

Thomas PK , et al: The phenotypic manifestations of chromosome 17p11.2 duplication . Brain 1997;120:465-478.

Gabreëls-Festen Aawm , et al: Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations . Acta Neuropathol 1995;90:645-649.

Tyson J. , et al: Missense mutations of the PMP22 and P0 genes in hereditary motor and sensory neuropathy. J Neurol 1996;243(Suppl 2):20.

Lenssen Ppa , et al: Hereditary neuropathy with liability to pressure palsies. Phenotypic differences between patients with the common deletion and a PMP22 frame shift mutation. Brain 1998; in press.

Gabreës-Festen Aawm , et al: Two divergent types of nerve pathology in patients with different P0 mutations. Neurology 1996;47:761-765.

Chapon F. , et al: A family presenting with electrophysiological 'CMT type II' and linked to P0 gene. Neuromuscul Disord 1997;7:472.

Martini R. : Animal models for inherited peripheral neuropathies. J Anat 1997;191:321-336.

Yuki N. , Yoshino H. , Sato S. , Miyatake T. : Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902.

Hafer-Macko CE , Hsieh ST , Li CY , et al: Acute motor axonal neuropathy: An antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644.

Epstein MA , Sladky JT : The role of plasmapheresis in childhood Guillain-Barré syndrome. Ann Neurol 1990;28:65-69.

Van der Meché Fga , Schmitz Pim , Dutch Guillain-Barré Study Group : A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-1129.

Hughes R. , Sanders E. , Hall S. , et al: Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol 1992;49:612-616.

Sladky JT , Brown MJ , Berman PH : Chronic inflammatory demyelinating polyneuropathy of infancy: A corticosteroid responsive disorder. Ann Neurol 1986;20:76-81.

Colan RV , Snead OC , Oh SJ , Benton JW : Steroid-responsive polyneuropathy with subacute onset in childhood . J Pediatr 1980;97:374-377.

Nevo Y. , Pestronk A. , Komberg AJ , et al: Childhood chronic inflammatory demyelinating neuropathies: Clinical course and long-term follow-up. Neurology 1996;47:98-102.

Prineas JW , McLeod JG : Chronic relapsing polyneuritis. J Neurol Sci 1976;27:427-458.

Vettaikorumakankav V. , Vedanarayanan MD , Kandt RS , et al: Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: Treatment with high-dose intravenous immunoglobulin. Neurology 1991 ;41:828-830.

Dyck PJ , Lais AC , Ohta M. , et al: Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-637.

McCombe PA , Pollard JD , McLeod JG : Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 1987;110:1617-1630.

Simmons Z. , Wald JJ , Albers JW : Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve 1997;20:1008-1015.

Simmons Z. , Wald JJ , Albers JW : Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults. Muscle Nerve 1997;20:1569-1575.

Austin JH : Recurrent polyneuropathies and their corticosteroid treatment—with five year observations on a placebo controlled case treated with corticotropin, cortisone and prednisone. Brain 1958;81:157-194.

Molenaar DS , Vermeulen M. , de Haan R. : Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64:84-89.

Al-Qudah AA , Shahar E. , Logan WJ , Murphy EG : Neonatal Guillain-Barré syndrome. Pediatr Neurol 1988;4:255-256.

Arnason Bgw , Soliven B. : Acute inflammatory demyelinating polyradiculoneuropathy, in Dyck PJ, Thomas PK, Griffin JW, et al: Peripheral Neuropathy, 3rd ed. Philadelphia, WB Saunders, 1993, pp 1437-1497.

Dyck PJ , Arnason Bwg : Chronic inflammatory demyelinating polyradiculoneuropathy, in Dyck PJ , Thomas PK , Lambert EH , Bunge R (eds): Peripheral Neuropathy, vol 2, 2nd ed. Philadelphia , WB Saunders, 1984, pp 2101-2114.

Griffin JW , Li CT , Ho TW , et al: Pathology of the motor-sensory axonal Guillain-Barré syndrome . Ann Neurol 1996;39:17-28.

Hahn AF , Bolton CF , Pillay N. , et al: Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 1996;119:1055-1066.

Hahn AF , Bolton CF , Zochodne D. , Feasby TE : Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996;119:1067-1077.

Jansen PW , Perkin RM , Ashwal S. : Guillain-Barré syndrome in childhood: Natural course and efficacy of plasmapheresis . Pediatr Neurol 1993;9:16-20.

Kanra G. , Ozon A. , Vajsar J. , et al: Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Eur J Paediatr Neurol 1997;1:7-12.

McKhann GM , Comblath DR , Griffin JW , et al: Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.

Takigawa T. , Yasuda H. , Kikkawa R. , et al: Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rate myelinated nerve fibers. Ann Neurol 1995;37:436-442.

Vajsar J. , Sloane A. , Wood E. , Murphy EG : Plasmapheresis versus intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome. Arch Pediatr Adolesc Med 1994;148:1210-1212.

Vallée L. , Dulac O. , Nuyts JP , et al: Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children. Neuropediatrics 1993;24:235-236.

Yuki N. : Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody . Ann Neurol 1996;39:668-672.